BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:LW231 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of LW231\, from ClinicalTrials.gov estimates
 .
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07179575-10218@assetmemo.bio
DTSTAMP:20261121T005831Z
DTSTART;VALUE=DATE:20270331
DTEND;VALUE=DATE:20270401
SUMMARY:LW231: Phase 1/2 readout est. (NCT07179575)
DESCRIPTION:LW231\, phase 1/2\, Chronic Hepatitis B.\nStudy: Study of LW231
  in Participants With Chronic Hepatitis B\nEstimated primary completion: M
 arch 2027. This is a ClinicalTrials.gov estimate\, not a confirmed readout
  date\, and it can move.\nDrug page: https://assetmemo.bio/drug/lw231#upco
 ming-events\nRegistry record: https://clinicaltrials.gov/study/NCT07179575
URL:https://assetmemo.bio/drug/lw231#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
